跳至主要内容
临床试验/CTRI/2025/05/086246
CTRI/2025/05/086246尚未招募不适用

Patterns and Outcomes of Coronary Artery Disease in Chronic Kidney Disease: Comparative Prospective Observational Study

Not Applicable1 个研究点 分布在 1 个国家目标入组 900 人开始时间: 2025年6月1日最近更新:

试验速览

阶段
不适用
状态
尚未招募
入组人数
900
试验地点
1
主要终点
To study the anatomy and morphology of coronary artery lesions in CKD and compare these with non-CKD patients.

研究概览

简要总结

This study aims to delve into the trends of lesions in the coronary artery and clinical outcomes in patients with CAD, both with and without CKD, who are undergoing CAG prospectively. The main emphasis will be on assessing the anatomy, quantity, and types of lesions in CAD patients with CKD compared to those with normal kidney function. Additionally, the prevalence of CAD in CKD patients undergoing CAG will be contrasted with the non-CKD cohort, followed by evaluating the CV outcomes such as 3-point Major Adverse Cardiac Events (3P-MACE) that include CV death, nonfatal MI, nonfatal stroke, 4P-MACE (additionally including unstable angina), 5P-MACE (further inclusion of hospitalization for heart failure (HHF), Mortality, and progression of CKD in these patient demographics, offering an understanding of comparative risks and the necessity for specific management strategies in CKD populations. Finally, a subgroup analysis will be done by comparing the above outcomes among CKD patients with and without comorbidities.

研究设计

研究类型
Observational

入排标准

年龄范围
18.00 Year(s) 至 80.00 Year(s)(—)
性别
All

入选标准

  • Patients undergoing Coronary Angiogram for the first time at the KMC hospital.

排除标准

  • Participants who decline participation; having incomplete medical records or missing essential data, are pregnant, have a documented history of prior CAG, PCI, or coronary artery bypass grafting (CABG), have severe valvular heart disease, or have a critical illness with a life expectancy of less than one year will be excluded.

结局指标

主要结局

To study the anatomy and morphology of coronary artery lesions in CKD and compare these with non-CKD patients.

时间窗: 24 months

次要结局

  • prevalence of CAD among CKD patients undergoing CAG and(compare it with non-CKD group with similar indications.)
  • cardiovascular outcomes (3P-MACE), (4P-MACE), and (5P-MACE)(24 months)
  • Comparison of (3P-MACE), (4P-MACE), (5P-MACE), Mortality, Progression of CKD among CKD patients with and without comorbidities(24 months)

研究者

申办方类型
Other [nil]
责任方
Principal Investigator
主要研究者

Dr Ravindra Prabhu A

Kasturba Medical College, MAHE, Manipal

研究点 (1)

Loading locations...

相似试验